APA

Gachard N., Parrens M., Soubeyran I., Petit B., Marfak A., Rizzo D., Devesa M., Delage-Corre M., Coste V., Laforêt M. P., de Mascarel A., Merlio J. P., Bouabdhalla K., Milpied N., Soubeyran P., Schmitt A., Bordessoule D., Cogné M. & Feuillard J. (20130228). IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. : Leukemia.

Chicago

Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt M P, de Mascarel A, Merlio J P, Bouabdhalla K, Milpied N, Soubeyran P, Schmitt A, Bordessoule D, Cogné M and Feuillard J. 20130228. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. : Leukemia.

Harvard

Gachard N., Parrens M., Soubeyran I., Petit B., Marfak A., Rizzo D., Devesa M., Delage-Corre M., Coste V., Laforêt M. P., de Mascarel A., Merlio J. P., Bouabdhalla K., Milpied N., Soubeyran P., Schmitt A., Bordessoule D., Cogné M. and Feuillard J. (20130228). IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. : Leukemia.

MLA

Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt M P, de Mascarel A, Merlio J P, Bouabdhalla K, Milpied N, Soubeyran P, Schmitt A, Bordessoule D, Cogné M and Feuillard J. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. : Leukemia. 20130228.